Skip to main content
Shionogi & Co.,Ltd. logo

Shionogi & Co.,Ltd. — Investor Relations & Filings

Ticker · 4507 ISIN · JP3347200002 LEI · 35380049VXDTHZI3DY35 T Manufacturing
Open in API
Filings indexed 83 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country JP Japan
Listing T 4507

About Shionogi & Co.,Ltd.

https://www.shionogi.com/global/en/

Shionogi & Co., Ltd. is a drug discovery-based pharmaceutical company that researches, develops, manufactures, and markets a portfolio of prescription drugs, over-the-counter (OTC) products, and diagnostic reagents. The company prioritizes addressing unmet medical needs, with a significant focus on infectious diseases, including antibiotics, HIV, influenza, and COVID-19. A key strategic area is the development of solutions to combat antimicrobial resistance (AMR). Historically, the company is known for the development of Crestor, a widely used statin. Shionogi aims to provide innovative products and services to improve global health outcomes.

Recent filings

Filing Released Lang Actions
(Corrections) Shionogi Announces FDA Approval of XOCOVA (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
Regulatory Filings Classification · 80% confidence The document is a corporate press release (including corrected release materials) announcing FDA approval of a pharmaceutical product and related corrections. It contains no actual financial statements or investor presentation slides, nor does it report on meetings, dividends, or insider transactions. It is a general regulatory announcement, fitting the Regulatory Filings category rather than a specific report type.
2026-06-01 English
Shionogi Announces FDA Approval of XOCOVA (ensitrelvir), the First and Only Oral Option to Help Prevent COVID-19 Following Exposure
Regulatory Filings Classification · 87% confidence The document is a corporate press release (“PRESSRELEASE”) announcing FDA approval of XOCOVA for COVID-19 post-exposure prophylaxis. It contains no financial statements, earnings figures, or shareholder vote results, and is not a formal annual or interim report, earnings release, or other specified filing. It is a general regulatory announcement and thus best fits the fallback category Regulatory Filings (RNS).
2026-06-01 English
抗新型コロナウイルス（SARS-CoV-2）薬 エンシトレルビル フマル酸の COVID-19 曝露後発症予防における米国FDAの承認について
Regulatory Filings Classification · 60% confidence The document is a corporate press release announcing FDA approval for a COVID-19 prophylactic drug. It does not contain financial statements, earnings results, board changes, or meeting materials. It is a general regulatory announcement (drug approval), fitting the fallback category for miscellaneous regulatory filings. Therefore, it is classified as Regulatory Filings (RNS).
2026-06-01 Japanese
Notice Regarding Approval of Naldemedine for Opioid-Induced Constipation in China
Regulatory Filings Classification · 85% confidence The document is a press release announcing regulatory approval of a pharmaceutical product by China’s National Medical Products Administration. It is not a financial or corporate governance report, nor a voting or dividend announcement. It does not present financial statements or detailed investor materials, so it falls into the general regulatory announcements category. Therefore, it is classified as a Regulatory Filing (RNS).
2026-05-29 English
オピオイド誘発性便秘症治療薬ナルデメジンの中国における新薬承認取得について
Regulatory Filings Classification · 60% confidence The document is a corporate press release announcing regulatory approval of a pharmaceutical product in China. It contains no financial statements, management changes, earnings data, or formal voting results. It is not an investor presentation or financial report, but rather a general company announcement. This does not fit any specific filing category other than the general catch-all for miscellaneous regulatory announcements. Therefore it is classified as a Regulatory Filing (RNS).
2026-05-29 Japanese
Fiscal 2025 Financial Results
Regulatory Filings
2026-05-12 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.